Trilliant Health, a Nashville, Tenn.-based analytics and data science company that empowers intelligent patient acquisition, received a major growth investment from Primus Capital.
Primus joins existing investors who also participated in the recapitalization, including Providence Ventures, Martin Ventures, Noro-Moseley Partners, and Nashville Capital Network. As a result of the transaction, Jeff Stolte, Senior Partner of Providence Ventures, has joined the Trilliant Board of Directors.
The amount of the deal was not disclosed.
The company intends to use the funds to continue building its data science and technology teams to enhance the capabilities of its analytics platform.
Led by Hal Andrews, President & CEO, Trilliant Health provides hospitals and healthcare providers with an analytics platform that uses advanced data science methodologies to combine claims data, household data, and user-generated data from digital marketing campaigns to support healthcare systems around strategy, consumer loyalty, site selection, M&A, payer negotiations, physician alignment, and marketing.
By synthesizing all-payer claims, household, and patient-generated data, Trilliant Health provides a comprehensive view into market dynamics that enables healthcare providers to find the most efficient and effective solutions for growth in their markets.
Today, the company works with over 70 healthcare systems across the nation.